Analyze Your LNP with Precise PKPD, Biodistribution, Immune Response for Applications in GTx Therapy, Vaccination & Beyond
The 2023 Conversation Included:
Robust analysis of LNPs to unpick driving factors behind immune response and immune cell engagement
Preclinical models from in vitro, animal models and 3D tissue models to optimize translatability into the clinic
Understanding of LNP immunogenicity and toxicity read-outs in relation to application of vaccine, gene therapy and chronic disease
Advanced immunogenicity models to minimize anti-PEG response, and PEG alternatives to minimize adverse effects
Widened therapeutic windows and well understood dose limiting toxicities for maximal efficacious benefit
Evaluation of the LNP-payload complex beyond mRNA for next-generation development
In collaboration with Pfizer, BioNTech, Sanofi and Bayer, this 3-day summit united senior leaders dedicated to understanding and predicting the next wave of LNP’s immunogenicity and toxicity challenges, to support drug developers to ensure smooth filing with long-term patient safety in mind.
World-Class Speaker Faculty Included:
Group Discounts:
10% discount - 3 delegates
15% discount - 4 delegates
20% discount - 5 or more delegates
*Please note that discounts are only valid when three or more delegates from one company book and pay at the same time. Discounts cannot be used in conjunction with any other offer or discount. Only one discount offer may be applied to the current pricing rate.
Current Partners:
